- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Lilly-backed scheme aims to help UK improve obesity care | ||
| Di | Novartis two for two as ianalumab scores again | ||
| Di | Bayer buys into KRAS with $1.3bn Kumquat deal | ||
| Di | Apple partners with FuturHealth on weight loss | ||
| Di | IO Bio plans cancer vaccine filing despite trial miss | ||
| Mo | FDA starts swift review of GSK antibiotic for gonorrhoea | ||
| Mo | MorphoSys takeover delivers phase 3 win for Novartis | ||
| Mo | FDA restricts use of bluebird's Skysona gene therapy | ||
| Mo | Boehringer back in cancer with Hernexeos approval | ||
| Mo | Vinay Prasad returns to FDA | ||
| Fr | Iovance cuts staff on slower cell therapy sales growth | ||
| Fr | GSK and CureVac settle mRNA patent spat with Pfizer/BioNTech | ||
| Fr | Click, Boehringer DTx for schizophrenia passes phase 3 test | ||
| Do | Strand raises $153m for RNA meds, and other bio financings | ||
| Do | FDA makes it easier to set up US manufacturing sites | ||
| Do | England poised to roll out drug for rare eye disease LHON | ||
| Do | Lilly weakens on oral weight-loss drug data | ||
| Do | Pushback against Kennedy's mRNA decision builds | ||
| Do | Jazz gets FDA okay for Chimerix brain cancer drug | ||
| Do | Rumour mill says Novartis may want to buy Avidity | ||
| 06.08. | Bayer's job cull nears 12,000, with more to come | ||
| 06.08. | Meta harvested health data to target ads, jury concludes | ||
| 06.08. | Novo Nordisk weakens again on interim results readout | ||
| 06.08. | New medicines review process under NHS 10-year plan emerges | ||
| 06.08. | RFK Jr cancels $500m in funding for mRNA vaccines |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .